Loading…
Baird Medical Investment Holdings Limited is projected to decline to $1.06 by 2027, a -6% move from its current price of $1.13. BDMD is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $1.09 | $1.13 | $1.17 | +0.07% |
| Jul 14 | $1.08 | $1.13 | $1.19 | +0.13% |
| Jul 15 | $1.07 | $1.13 | $1.20 | +0.20% |
| Jul 16 | $1.06 | $1.13 | $1.22 | +0.27% |
| Jul 17 | $1.05 | $1.13 | $1.23 | +0.33% |
| Jul 18 | $1.04 | $1.13 | $1.24 | +0.40% |
| Jul 19 | $1.03 | $1.14 | $1.25 | +0.47% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.03 | $1.14 | $1.25 | +0.47% |
| Week 2 | $0.9995 | $1.14 | $1.30 | +0.94% |
| Week 3 | $0.9748 | $1.15 | $1.35 | +1.41% |
| Week 4 | $0.9551 | $1.15 | $1.39 | +1.88% |
| Week 5 | $0.9387 | $1.16 | $1.43 | +2.36% |
| Week 6 | $0.9244 | $1.16 | $1.46 | +2.83% |
| Week 7 | $0.9119 | $1.17 | $1.49 | +3.31% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
BDMD is Baird Medical Investment Holdings Limited, a healthcare company that engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People’s Republic of China. The company offers microwave ablation apparatus and needles; and long and fine microwave ablation needles for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps, and uterine fibroids, as well as soft tissue ablation. It sells its products through third-party distributors.
BDMD was founded in 2012 and is based in Guangzhou, China.
BDMD is currently priced at $1.14, with a market capitalization of $36.46M and a market rank of 4454. The near-term price action is supported by a mixed outlook across the year-by-year forecasts, with several years showing bullish momentum and others weaker or neutral.
The forecast pathway includes notable upside in later years, such as 2032 with an average of $1.40 and a max of $2.36 (ROI 22.7) and 2040 with an average of $1.62 and a max of $3.15 (ROI 41.7), culminating in 2050 with an average of $3.27 and a max of $7.17 (ROI 187.1). The early years show more modest or negative readings in some cases, reflecting a volatile trajectory.
A major floor 44.2% below — a decisive break under it would weaken the trend.
The nearest floor, 13.3% below — buyers have tended to step in here.
The nearest ceiling, 39.8% above — a clean break opens room to run.
A major ceiling 204.4% above — clearing it would confirm fresh momentum.
Key BDMD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BDMD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.15 | Sell | $1.14 | Sell |
| MA 10 | $1.14 | Sell | $1.14 | Sell |
| MA 20 | $1.13 | Sell | $1.17 | Sell |
| MA 50 | $1.40 | Sell | $1.35 | Sell |
| MA 100 | $1.73 | Sell | $1.52 | Sell |
| MA 200 | $1.57 | Sell | $1.93 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 41.44 | Neutral |
| Stoch RSI (14) | 83.27 | Sell |
| CCI (20) | -4.24 | Neutral |
| Williams %R (14) | -25.00 | Info |
| MACD (12,26,9) | 0.03 | Buy |
| ROC (12) | 10.78 | Buy |
| Bollinger %B (20,2) | 0.49 | Neutral |
| Stochastic %K (14) | 75.00 | Neutral |
| TRIX (15) | -1.09 | Sell |
| Awesome (5,34) | -0.11 | Sell |
| Ultimate (7,14,28) | 45.46 | Neutral |
| Momentum (10) | 0.14 | Buy |
| Aroon Osc (25) | -52.00 | Sell |
| Hull MA (9) | 1.15 | Sell |
| ADX (14) | 25.71 | Sell |
| ATR (14) | 0.04 | Info |
The 30-day technical picture is NEUTRAL. The RSI(14) sits at 40, with the price hovering near the SMA50 at $1.50 and the SMA200 at $1.62. The near-term price range over the last 30 days spans from $0.871 to $1.49, indicating the stock has traded within a tight band around the current level.
On a near-term support/resistance basis, support sits at $0.98 and resistance at $1.67. The stock also carries an annualized volatility of 80, underscoring a high level of price movement potential relative to more stable peers.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.77 | $1.13 | $1.49 | 0% | Neutral | |
| $0.8209 | $1.06 | $1.46 | -6% | Neutral | |
| $0.6988 | $0.9365 | $1.35 | -17% | Bearish | |
| $0.7643 | $1.06 | $1.58 | -6% | Neutral | |
| $0.7746 | $1.10 | $1.70 | -3% | Neutral | |
| $0.8422 | $1.23 | $1.94 | +9% | Neutral | |
| $0.9198 | $1.37 | $2.22 | +22% | Bullish | |
| $0.8276 | $1.26 | $2.09 | +12% | Neutral | |
| $0.7844 | $1.22 | $2.06 | +8% | Neutral | |
| $0.7775 | $1.24 | $2.12 | +10% | Neutral | |
| $0.9205 | $1.61 | $2.98 | +43% | Bullish | |
| $1.58 | $3.28 | $6.73 | +190% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.77 | $1.13 | $1.35 | +0.00% |
| August 2026 | $0.9849 | $1.17 | $1.44 | +3.71% |
| September 2026 | $0.9999 | $1.20 | $1.49 | +2.45% |
| October 2026 | $0.9621 | $1.16 | $1.47 | -3.02% |
| November 2026 | $0.9421 | $1.15 | $1.46 | -1.42% |
| December 2026 | $0.9488 | $1.16 | $1.49 | +1.33% |
Click any year to see its month-by-month BDMD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, BDMD is projected to trade between $0.77 and $1.49, averaging $1.13 — a potential gain of 0% from today's $1.13. Price action looks broadly range-bound.
Baird Medical Investment Holdings Limited's 2027 outlook centres on $1.06, within a $0.8209 to $1.46 range. That is -6% versus the projected 2026 average. That marks a -6% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, BDMD could reach as high as $1.35, with a base case around $0.9365 and support toward $0.6988 — roughly -17% from $1.13. A cyclical pullback looks likely — prices rarely move in a straight line.
Expect BDMD to range from $0.7643 to $1.58 through 2029. The $1.06 average target implies a -6% move from current prices. That is up +13% on the projected 2028 average. A consolidation phase looks the most probable path here.
The BDMD price prediction for 2030 points to an average of $1.10 (low $0.7746, high $1.70) — a potential decline of -3% on today's $1.13. Price action looks broadly range-bound.
In 2031, BDMD is projected to trade between $0.8422 and $1.94, averaging $1.23 — a potential gain of +9% from today's $1.13. That is up +12% on the projected 2030 average. A consolidation phase looks the most probable path here.
Baird Medical Investment Holdings Limited's 2032 outlook centres on $1.37, within a $0.9198 to $2.22 range. That is up +12% on the projected 2031 average. That marks a +22% change versus current levels. Momentum favours further upside here.
By 2033, BDMD could reach as high as $2.09, with a base case around $1.26 and support toward $0.8276 — roughly +12% from $1.13. A consolidation phase looks the most probable path here.
Expect BDMD to range from $0.7844 to $2.06 through 2034. The $1.22 average target implies a +8% move from current prices. That is -3% versus the projected 2033 average. Price action looks broadly range-bound.
The BDMD price prediction for 2035 points to an average of $1.24 (low $0.7775, high $2.12) — a potential gain of +10% on today's $1.13. A consolidation phase looks the most probable path here.
In 2040, BDMD is projected to trade between $0.9205 and $2.98, averaging $1.61 — a potential gain of +43% from today's $1.13. That is up +30% on the projected 2035 average. Momentum favours further upside here.
Baird Medical Investment Holdings Limited's 2050 outlook centres on $3.28, within a $1.58 to $6.73 range. That is up +103% on the projected 2040 average. That marks a +190% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in BDMD today (≈ 884.955752 BDMD) could be worth
$2,903.44
+$1,903.44 (+190%) by 2050 · US Dollar
Based on the average projected BDMD price of $3.28 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BDMDwould be worth at today's price.
$1,000 invested in BDMD on Jul 10, 2025 (≈ 284.090911 BDMD) would be worth
$321.02
-$678.98 (-67.9%) today · 0.32× · US Dollar
Based on a BDMD entry price of $3.52 vs. today's $1.13.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.18 | $957.63 | -4.2% |
| 1 month ago | $1.26 | $896.83 | -10.3% |
| 3 months ago | $1.77 | $638.42 | -36.2% |
| 6 months ago | $1.32 | $856.06 | -14.4% |
| 1 year ago | $3.52 | $321.02 | -67.9% |
| All time (4.6y) ago | $9.67 | $116.86 | -88.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BDMD forecast.
Our base-case forecast reaches $2.30 around 2050.
Implied market cap at $2.30: $73.56M
The multi-year forecast paints a path of mixed sentiment early on, with neutral readings for 2026 and 2027 and a shift to bullish momentum beginning in 2032. The 2030 forecast shows a min of $0.7374, an average of $1.09, and a max of $1.75, with a -4.4 ROI and NEUTRAL sentiment. In 2031, the min is $0.8173, the avg $1.25, the max $2.05, with a 9.2 ROI and NEUTRAL sentiment.
The bullish inflection appears in 2032, with a min of $0.8919, an avg of $1.40, and a max of $2.36, and a 22.7 ROI. 2033 remains NEUTRAL (min $0.7656, avg $1.23, max $2.13; ROI 8.2), followed by continued NEUTRAL readings through 2035. The forecast then turns strongly bullish by 2040 (min $0.8454, avg $1.62, max $3.15; ROI 41.7) and culminates in 2050 (min $1.47, avg $3.27, max $7.17; ROI 187.1).
Overall, the longer-range trajectory suggests meaningful upside in the later years, albeit with substantial variability along the way. These figures are estimates and not guarantees, and actual results can differ due to market conditions and other factors.
Tap a question to reveal the answer.
The forecast for 2030 shows min $0.7374, avg $1.09, max $1.75, ROI -4.4, sentiment NEUTRAL.
Forecasts show a mix of neutral, bearish, and bullish readings over the horizon, including 2032 (avg $1.40, ROI 22.7) and 2040 (avg $1.62, ROI 41.7) as bullish years, with some years like 2028 showing bearish momentum (avg $0.9221, ROI -19.1). However these are estimates and not guarantees.
The 2050 max forecast is $7.17, with an average of $3.27 and ROI 187.1, which would imply potential above current levels in a favorable scenario, but this is not guaranteed.
The 30-day range is $0.871 to $1.49; RSI(14) is 40; SMA50 is $1.50; SMA200 is $1.62; support is $0.98 and resistance is $1.67; sentiment is NEUTRAL.
The current price is $1.14; market cap is $36.46M; rank 4454. The company operates in the Healthcare sector in China, focusing on microwave ablation devices and related products.
Baird Medical Investment Holdings Limited Community Discussion
0Share your Baird Medical Investment Holdings Limited price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.